GlassScriptPhysician profile
Giulia Marie Vasquez
NPI 1851941983
$8,977.78
in general payments reported to CMS, 2019-2025
28 companies · $1,130 in 2025
The $1,130 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $913 · 2022: $3,289 · 2023: $1,874 · 2024: $1,772 · 2025: $1,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,775.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,813.38 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $1,550.97 | 2022-2025 | In.Pact Admiral, Hawkone, Valiant Captivia |
| W. L. Gore & Associates, INC. | $1,324.10 | 2021-2025 | Gore Excluder Iliac Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Endoprosthesis |
| Cvrx, INC. | $967.95 | 2021-2025 | Barostim Neo System |
| Shockwave Medical, INC | $669.10 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $450.90 | 2021-2022 | |
| Inari Medical, INC. | $268.85 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $263.80 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $253.02 | 2021-2024 | Ingrezza |
| Smith+Nephew, INC. | $177.70 | 2022-2024 | Pico, Stravix |
| Inspiremd LTD | $171.88 | 2025 | Cguard Prime Carotid Stent System |
| Baxter Healthcare | $159.57 | 2022-2025 | Floseal |
| Janssen Pharmaceuticals, INC | $159.33 | 2022-2023 | Xarelto |
| Lilly USA, LLC | $111.13 | 2023 | Mounjaro |
| Bard Peripheral Vascular, INC. | $91.33 | 2023-2025 | Crosser Iq, Crosser Iq |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $88.81 | 2024-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Penumbra, INC. | $80.00 | 2021 | |
| Atricure, INC. | $77.95 | 2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Dilon Technologies, INC. | $71.53 | 2024 | Hemoblast Bellows |
| Pfizer INC. | $46.19 | 2021-2023 | |
| Philips North America LLC | $32.18 | 2025 | Labosys |
| Lifenet Health | $31.82 | 2024 | Theragenesis Wound Matrix |
| Acera Surgical, INC. | $28.16 | 2025 | Restrata Wound Matrix |
| Cardiovascular Systems INC. | $21.60 | 2021 | |
| Becton, Dickinson and Company | $19.18 | 2025 | Denali Vena Cava Filter |
| Livanova USA, INC. | $17.12 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Solventum Corporation | $15.80 | 2024 | Prevena, V.A.C.Ulta |
| Contego Medical, INC | $14.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giulia Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.